Skip to main content

Deutsche Bank investors took a largely long view on its failure in this year’s U.S. stress tests, with its shares recovering on Friday from a record low hit earlier this week.

Goldman Sachs analysts said the U.S. Federal Reserve’s issues with Deutsche Bank were “long standing” and “not new,” while UBS said the failure was “not a total surprise.”

The Fed last year classified Deutsche Bank’s U.S. unit as troubled and Deutsche Bank’s shares had been falling in anticipation of the stress test verdict on Thursday.

Story continues below advertisement

Shares in the German bank, which are down 42 per cent this year, were up 1.4 per cent at 9.19 euros at 1401 GMT, above Wednesday’s record low of 8.76 euros.

The test was the second stage in the Fed’s annual health check of banks. Deutsche Bank passed the first phase last week, but was the only lender to fail the second, in another blow to its fragile reputation as it struggles to revive profitability.

The Fed, which regularly checks banks’ financial strength, cited “widespread and critical deficiencies” in Deutsche Bank’s capital planning controls.

“It does seems like Deutsche Bank at the moment is the worst student in the class that can’t get anything right,” said Octavio Marenzi, CEO of consultancy Opimas.

Deutsche Bank Chief Executive Officer Christian Sewing said the bank was making “good progress” on improving.

“We are completely committed to work with authorities to get that even better ... over the next year,” Sewing said in an interview on CNBC on Friday.

The bank said on Thursday it had made significant investments to improve its capital planning capabilities, controls and infrastructure at its U.S. subsidiary.

Story continues below advertisement

The European Central Bank, which oversees Deutsche Bank, and German financial market watchdog BaFin both declined to comment.

Deutsche Bank will now need to obtain the Fed’s permission before making capital payouts to its German parent.

But the overall impact will be limited, Marenzi said. The bank may need to invest just about $10 million in additional stress testing technology and external consultants.

Michael Huenseler, head of credit portfolio management at Assenagon, said the Fed’s assessment could spook clients in the United States just as the bank tries to regain its footing there after announcing deep cuts in its U.S. and Asian operations.

“The U.S. plays a major role for their investment banking revenues and if the U.S. doesn’t deliver the results they are expecting, what else does compensate for this? That is really a concern,” Huenseler said.

Analysts at UBS said that, while expected, the Fed’s results are “an unwelcome outcome as it adds to weak sentiment and we think various stakeholders such as clients/counterparts could raise concerns.”

Story continues below advertisement

The Fed’s assessment follows months of turmoil at Deutsche, which abruptly reshuffled management in April after three consecutive years of losses. It then began plans to scale back its investment bank to refocus on Europe and its home market.

It has flagged cuts to U.S. bond trading, equities and the business that serves hedge funds.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter